Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biopsy, Fine-Needle | 3 | 2009 | 101 | 0.560 |
Why?
|
| Barrett Esophagus | 5 | 2014 | 349 | 0.360 |
Why?
|
| Breast Neoplasms, Male | 1 | 2009 | 18 | 0.300 |
Why?
|
| Carcinoma | 1 | 2009 | 283 | 0.250 |
Why?
|
| Bacterial Infections | 1 | 2008 | 327 | 0.210 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 204 | 0.210 |
Why?
|
| Felty Syndrome | 1 | 2023 | 2 | 0.210 |
Why?
|
| Protein Kinase C | 3 | 1999 | 113 | 0.210 |
Why?
|
| Hand Dermatoses | 1 | 2023 | 9 | 0.200 |
Why?
|
| Sweet Syndrome | 1 | 2023 | 10 | 0.200 |
Why?
|
| Isoenzymes | 3 | 1999 | 212 | 0.200 |
Why?
|
| Dermatitis | 1 | 2023 | 27 | 0.200 |
Why?
|
| Skin Diseases | 1 | 2023 | 142 | 0.180 |
Why?
|
| Neutropenia | 1 | 2023 | 209 | 0.180 |
Why?
|
| Adenocarcinoma | 4 | 2011 | 968 | 0.180 |
Why?
|
| Gastritis | 2 | 2017 | 374 | 0.170 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 150 | 0.160 |
Why?
|
| Colorectal Neoplasms | 3 | 2011 | 612 | 0.150 |
Why?
|
| Breast | 2 | 2009 | 213 | 0.130 |
Why?
|
| Colon | 2 | 2007 | 363 | 0.130 |
Why?
|
| Diet | 2 | 2013 | 1103 | 0.120 |
Why?
|
| Aged | 16 | 2017 | 20818 | 0.120 |
Why?
|
| Waist-Hip Ratio | 2 | 2013 | 53 | 0.120 |
Why?
|
| Helicobacter Infections | 3 | 2014 | 1311 | 0.110 |
Why?
|
| Aged, 80 and over | 9 | 2017 | 6764 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2015 | 70 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 108 | 0.100 |
Why?
|
| Helicobacter pylori | 2 | 2014 | 1371 | 0.100 |
Why?
|
| Glycation End Products, Advanced | 1 | 2013 | 25 | 0.100 |
Why?
|
| Meat | 1 | 2013 | 45 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2013 | 40 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2013 | 56 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 4 | 2014 | 152 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2013 | 133 | 0.090 |
Why?
|
| Middle Aged | 12 | 2023 | 28315 | 0.090 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2013 | 77 | 0.090 |
Why?
|
| Logistic Models | 5 | 2014 | 1797 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2013 | 111 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2076 | 0.080 |
Why?
|
| Vegetables | 1 | 2013 | 264 | 0.080 |
Why?
|
| Folic Acid | 1 | 2013 | 269 | 0.080 |
Why?
|
| Antioxidants | 1 | 2013 | 331 | 0.080 |
Why?
|
| Myocardium | 1 | 2015 | 860 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 521 | 0.080 |
Why?
|
| Biopsy | 2 | 2012 | 1240 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2014 | 3351 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 2009 | 89 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2011 | 210 | 0.070 |
Why?
|
| Psoas Muscles | 1 | 2008 | 6 | 0.070 |
Why?
|
| Male | 16 | 2023 | 64425 | 0.070 |
Why?
|
| Muscle Neoplasms | 1 | 2008 | 21 | 0.070 |
Why?
|
| Mycobacterium Infections | 1 | 2008 | 35 | 0.070 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 23 | 0.070 |
Why?
|
| Risk Factors | 7 | 2017 | 10967 | 0.060 |
Why?
|
| Mycoses | 1 | 2008 | 110 | 0.060 |
Why?
|
| Humans | 19 | 2023 | 130204 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 283 | 0.060 |
Why?
|
| Adult | 8 | 2017 | 31035 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2012 | 1694 | 0.060 |
Why?
|
| Adenoma, Villous | 1 | 2006 | 2 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2013 | 1210 | 0.060 |
Why?
|
| Mammary Glands, Animal | 2 | 1999 | 448 | 0.060 |
Why?
|
| Anus Neoplasms | 1 | 2006 | 40 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 3798 | 0.050 |
Why?
|
| Carcinoma, Medullary | 1 | 2004 | 17 | 0.050 |
Why?
|
| Hyperthyroidism | 1 | 2004 | 24 | 0.050 |
Why?
|
| Filgrastim | 1 | 2023 | 13 | 0.050 |
Why?
|
| Blister | 1 | 2023 | 18 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2007 | 687 | 0.050 |
Why?
|
| Female | 14 | 2017 | 70342 | 0.050 |
Why?
|
| Prevalence | 3 | 2017 | 2691 | 0.050 |
Why?
|
| Hernia, Hiatal | 2 | 2013 | 55 | 0.050 |
Why?
|
| Cytodiagnosis | 1 | 2002 | 18 | 0.050 |
Why?
|
| False Negative Reactions | 1 | 2002 | 90 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2885 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 996 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2002 | 332 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1999 | 1109 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 979 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 1799 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2002 | 410 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2057 | 0.040 |
Why?
|
| Lactation | 2 | 1999 | 195 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2002 | 765 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1532 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 1376 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 95 | 0.030 |
Why?
|
| Rats | 3 | 1999 | 3372 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 242 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 902 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1998 | 1014 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 1998 | 262 | 0.030 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 1 | 2015 | 12 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 951 | 0.030 |
Why?
|
| Texas | 2 | 2013 | 3655 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 1998 | 1907 | 0.030 |
Why?
|
| Etidronic Acid | 1 | 2013 | 10 | 0.030 |
Why?
|
| Alendronate | 1 | 2013 | 22 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 172 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 763 | 0.020 |
Why?
|
| Lysine | 1 | 2013 | 165 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 2013 | 78 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2015 | 205 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 4036 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2015 | 449 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 3713 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 261 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2014 | 241 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1592 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 136 | 0.020 |
Why?
|
| Prognosis | 2 | 2011 | 4847 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 631 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2013 | 275 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2013 | 323 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2006 | 588 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 425 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2008 | 17577 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 491 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2015 | 972 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2009 | 155 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 1999 | 89 | 0.020 |
Why?
|
| Echocardiography | 1 | 2015 | 1131 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2009 | 119 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 84 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 384 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 387 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 155 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 122 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 631 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 399 | 0.020 |
Why?
|
| Animals | 4 | 2007 | 33676 | 0.020 |
Why?
|
| Mice | 2 | 2007 | 18173 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1069 | 0.020 |
Why?
|
| Spleen | 1 | 2007 | 258 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 239 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1212 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2007 | 699 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 1278 | 0.010 |
Why?
|
| Anal Canal | 1 | 2006 | 88 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 356 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2190 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 1999 | 905 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 1001 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 113 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 533 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 980 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 6407 | 0.010 |
Why?
|
| Veterans | 1 | 2013 | 1752 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 12824 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 2401 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1999 | 92 | 0.010 |
Why?
|
| Sexual Maturation | 1 | 1999 | 45 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 114 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1999 | 117 | 0.010 |
Why?
|
| Milk | 1 | 1998 | 109 | 0.010 |
Why?
|
| United States | 1 | 2013 | 11959 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 4642 | 0.010 |
Why?
|
| Organoids | 1 | 1999 | 297 | 0.010 |
Why?
|
| Pregnancy | 2 | 1999 | 7456 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1998 | 823 | 0.010 |
Why?
|